Hydroxyzine Hydrochloride

盐酸羟嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHydroxyzine Hydrochloride
Drug Alias Namehidroxizina盐酸羟秦羟嗪盐酸盐hydroxyzinum羟秦盐酸盐 +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsAnxiety DisordersAnxietyUrticaria +[4
Global Approved IndicationsAnxiety DisordersAnxietyUrticaria +[4
Approved Indications in ChinaAnxiety
Original Approved Country/TerritoryUnited States
Original Approved Date1956/04/12
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdvanz Pharma Corp
Inactive CompaniesPfizer Inc
Active IndicationsAnxiety
Inactive IndicationsAnxiety DisordersUrticariaPruritus

Other Information

ATC CodeN05BB01